Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bostwick

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Science Translational Medicine|January 6, 2017
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleedingPancras C Wong, Dietmar Seiffert, J Eileen Bird, et al.
Journal of Medicinal Chemistry|February 2, 2013
Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonistsHannguang Chao, Huji Turdi, Timothy F Herpin, et al.
Journal of Medicinal Chemistry|October 30, 2013
Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonistJennifer X Qiao, Tammy C Wang, Réjean Ruel, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2014
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agentYoon T Jeon, Wu Yang, Jennifer X Qiao, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Science Translational Medicine|January 6, 2017
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleedingPancras C Wong, Dietmar Seiffert, J Eileen Bird, et al.
Journal of Medicinal Chemistry|February 2, 2013
Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonistsHannguang Chao, Huji Turdi, Timothy F Herpin, et al.
Journal of Medicinal Chemistry|October 30, 2013
Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonistJennifer X Qiao, Tammy C Wang, Réjean Ruel, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2014
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agentYoon T Jeon, Wu Yang, Jennifer X Qiao, et al.
Pageof 4